Skip to main content
Skip to main content
CLOV logo

Clover Health Investments, Corp. (CLOV)

For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Clover Health Investments, Corp. (CLOV) trades at $1.75 with AI Score 49/100 (Weak). Clover Health Investments, Corp. operates as a Medicare Advantage insurer, leveraging its Clover Assistant platform to provide health plans for Medicare-eligible consumers. Market cap: $895.96M, Sector: Healthcare.

Last analyzed: Feb 8, 2026
Clover Health Investments, Corp. operates as a Medicare Advantage insurer, leveraging its Clover Assistant platform to provide health plans for Medicare-eligible consumers. The company also focuses on non-insurance businesses.
49/100 AI Score Target $3.00 (+71.4%) MCap $895.96M Vol 3.69M

Clover Health Investments, Corp. (CLOV) Healthcare & Pipeline Overview

CEOAndrew Toy
Employees570
HeadquartersFranklin, TN, US
IPO Year2020

Clover Health is revolutionizing Medicare Advantage with its Clover Assistant platform, offering data-driven, personalized healthcare plans. Targeting improved patient outcomes and reduced costs, Clover Health presents a compelling investment in the evolving healthcare landscape, despite current profitability challenges and a volatile market.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Feb 8, 2026

Investment Thesis

Clover Health presents a compelling, albeit high-risk, investment opportunity within the Medicare Advantage market. The company's Clover Assistant platform offers a unique competitive advantage by leveraging data analytics to improve patient outcomes and reduce costs. While currently unprofitable with a profit margin of -3.3% and a P/E ratio of -18.73, the potential for significant growth exists as Clover Health expands its membership base and optimizes its operational efficiency. Key value drivers include the continued adoption of the Clover Assistant by physicians, expansion into new geographic markets, and the development of additional non-insurance revenue streams. The company's focus on underserved populations also aligns with broader healthcare trends and government initiatives. Investors should monitor key metrics such as membership growth, medical cost ratios, and the effectiveness of the Clover Assistant in improving patient outcomes. The company's high beta of 2.15 indicates significant volatility, making it suitable for investors with a higher risk tolerance.

Based on FMP financials and quantitative analysis

Key Highlights

  • Market Cap of $1.10B reflects investor valuation of Clover Health's growth potential in the Medicare Advantage market.
  • Gross Margin of 21.2% indicates the profitability of Clover Health's core insurance operations.
  • Negative Profit Margin of -3.3% highlights the company's current unprofitability, requiring close monitoring of cost management and revenue growth.
  • Clover Assistant platform differentiates Clover Health by providing data-driven insights to physicians, potentially leading to improved patient outcomes and reduced costs.
  • Focus on non-insurance businesses provides diversification and potential for new revenue streams.

Competitors & Peers

Strengths

  • Innovative Clover Assistant platform for data-driven care.
  • Focus on underserved populations and health equity.
  • Potential for improved patient outcomes and cost management.
  • Strong brand reputation for innovation.

Weaknesses

  • Current unprofitability and negative profit margin.
  • High beta indicating significant stock volatility.
  • Relatively small market share compared to larger insurers.
  • Dependence on regulatory changes in the Medicare Advantage market.

Catalysts

  • Continued expansion of Clover Assistant platform to new markets.
  • Potential partnerships with healthcare providers and ACOs in 2026.
  • Development and launch of new non-insurance healthcare services.
  • Positive clinical trial results demonstrating improved patient outcomes.

Risks

  • Intense competition from larger, more established Medicare Advantage insurers.
  • Regulatory changes impacting reimbursement rates and coverage policies.
  • Data breaches and privacy concerns related to patient data.
  • Economic downturn impacting healthcare spending and enrollment.
  • Inability to achieve profitability and manage medical costs effectively.

Growth Opportunities

  • Expansion into New Geographic Markets: Clover Health has the opportunity to expand its Medicare Advantage plans into new geographic markets, targeting regions with high concentrations of Medicare-eligible individuals and underserved populations. This expansion can be achieved through organic growth, partnerships with local healthcare providers, or acquisitions of smaller regional insurers. The Medicare Advantage market is estimated to reach $400 billion by 2027, providing ample opportunity for Clover Health to increase its market share.
  • Increased Adoption of Clover Assistant: Driving increased adoption of the Clover Assistant platform among physicians is crucial for improving patient outcomes and reducing medical costs. This can be achieved through targeted marketing campaigns, incentives for physicians to use the platform, and ongoing training and support. The platform's ability to provide real-time, actionable insights at the point of care differentiates Clover Health from traditional Medicare Advantage insurers.
  • Development of Non-Insurance Revenue Streams: Clover Health can leverage its technology and data analytics capabilities to develop new non-insurance revenue streams, such as providing data analytics services to other healthcare providers or developing new software applications for managing chronic conditions. These new revenue streams can diversify the company's revenue base and reduce its reliance on its core insurance business. The market for healthcare data analytics is estimated to reach $70 billion by 2028.
  • Partnerships with Healthcare Providers: Forming strategic partnerships with healthcare providers, such as hospitals, physician groups, and accountable care organizations (ACOs), can help Clover Health improve its network coverage, enhance its care coordination capabilities, and reduce medical costs. These partnerships can also provide Clover Health with access to new patient populations and opportunities to expand its service offerings. Value-based care arrangements are increasingly common, incentivizing collaboration.
  • Focus on Underserved Populations: Clover Health's focus on serving underserved populations, such as low-income individuals and those with chronic conditions, aligns with broader healthcare trends and government initiatives. This focus can help the company attract new members, improve its brand reputation, and qualify for government subsidies and incentives. Addressing health equity is a growing priority for policymakers and healthcare providers.

Opportunities

  • Expansion into new geographic markets.
  • Increased adoption of Clover Assistant by physicians.
  • Development of non-insurance revenue streams.
  • Partnerships with healthcare providers and ACOs.

Threats

  • Intense competition from established Medicare Advantage insurers.
  • Regulatory changes and reimbursement pressures.
  • Potential for data breaches and privacy concerns.
  • Economic downturn impacting healthcare spending.

Competitive Advantages

  • Clover Assistant platform provides a technological advantage in data-driven care.
  • Focus on underserved populations creates a niche market with growth potential.
  • Data analytics capabilities enable improved patient outcomes and cost management.
  • Brand reputation for innovation and commitment to health equity.

About CLOV

Clover Health Investments, Corp., founded in 2014 and headquartered in Franklin, Tennessee, operates as a Medicare Advantage insurer in the United States. The company distinguishes itself through its technology-driven approach to healthcare, primarily through its Clover Assistant platform. This software platform provides preferred provider organization (PPO) and health maintenance organization (HMO) health plans for Medicare-eligible consumers. Clover Assistant aggregates and analyzes patient data to provide physicians with real-time, actionable insights at the point of care, aiming to improve clinical decision-making and patient outcomes. Beyond its insurance offerings, Clover Health also focuses on non-insurance businesses, exploring opportunities to leverage its technology and data analytics capabilities in broader healthcare applications. The company's mission is to improve health equity and access to quality care for underserved populations. Clover Health's innovative approach and focus on technology differentiate it from traditional Medicare Advantage insurers, positioning it as a disruptor in the healthcare industry. Despite its relatively young age, Clover Health has rapidly expanded its geographic footprint and membership base, demonstrating the appeal of its value proposition to both patients and providers. The company's commitment to data-driven healthcare and its focus on improving patient outcomes are central to its long-term growth strategy.

What They Do

  • Operates as a Medicare Advantage insurer in the United States.
  • Provides preferred provider organization (PPO) and health maintenance organization (HMO) health plans.
  • Offers health plans for Medicare-eligible consumers.
  • Utilizes the Clover Assistant, a software platform for data-driven insights.
  • Focuses on improving patient outcomes and reducing healthcare costs.
  • Serves underserved populations with a focus on health equity.
  • Explores non-insurance business opportunities.

Business Model

  • Generates revenue from premiums paid by Medicare Advantage members.
  • Manages medical costs through its Clover Assistant platform and care coordination programs.
  • Seeks to improve patient outcomes and reduce hospital readmissions.
  • Explores revenue opportunities in non-insurance healthcare services.

Industry Context

Clover Health operates within the rapidly growing Medicare Advantage market, which is projected to continue expanding as the population ages. The industry is characterized by increasing competition among insurers, a growing emphasis on value-based care, and the adoption of new technologies to improve efficiency and patient outcomes. Clover Health's focus on technology and data analytics aligns with these trends, positioning it as a potential disruptor in the market. Competitors include established players such as BGM, CERT, GPCR, GRDN, and LFST, as well as larger national insurers. The company's success will depend on its ability to differentiate itself through its technology platform and its ability to effectively manage medical costs.

Key Customers

  • Medicare-eligible individuals seeking comprehensive health coverage.
  • Physicians and healthcare providers who utilize the Clover Assistant platform.
  • Healthcare organizations seeking data analytics and care coordination solutions.
  • Underserved populations with limited access to quality healthcare.
AI Confidence: 72% Updated: Feb 8, 2026

CLOV Financials

CLOV Price Today & Live Chart

Clover Health Investments, Corp. (CLOV) stock price: $1.75 (-0.05, -2.78%)

CLOV Latest News

CLOV Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CLOV.

Price Targets

Consensus target: $3.00

CLOV MoonshotScore

49/100

What does this score mean?

The MoonshotScore rates CLOV's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Common Questions About CLOV (Healthcare)

What does Clover Health Investments, Corp. do?

Clover Health operates as a Medicare Advantage insurer in the United States, offering PPO and HMO health plans to Medicare-eligible consumers. The company differentiates itself through its Clover Assistant platform, a software solution that provides physicians with real-time, actionable insights at the point of care. This platform aims to improve clinical decision-making, patient outcomes, and cost management. Clover Health also focuses on serving underserved populations and exploring non-insurance business opportunities, positioning itself as an innovative player in the evolving healthcare landscape.

Is CLOV stock worth researching?

CLOV stock presents a high-risk, high-reward investment opportunity. While the company is currently unprofitable with a negative profit margin, its Clover Assistant platform and focus on underserved populations offer significant growth potential. Investors should carefully consider the company's financial performance, competitive landscape, and regulatory environment before investing. Key metrics to monitor include membership growth, medical cost ratios, and the effectiveness of the Clover Assistant in improving patient outcomes. The stock's high beta indicates significant volatility, making it suitable for investors with a higher risk tolerance and a long-term investment horizon.

What are the main risks for CLOV?

Clover Health faces several key risks, including intense competition from larger, more established Medicare Advantage insurers, potential regulatory changes impacting reimbursement rates and coverage policies, and the risk of data breaches and privacy concerns related to patient data. Additionally, an economic downturn could impact healthcare spending and enrollment, and the company's ability to achieve profitability and manage medical costs effectively is crucial for its long-term success. Investors should carefully assess these risks before investing in CLOV stock.

What are the key factors to evaluate for CLOV?

Clover Health Investments, Corp. (CLOV) currently holds an AI score of 49/100, indicating low score. Analysts target $3.00 (+71% from $1.75). Key strength: Innovative Clover Assistant platform for data-driven care. Primary risk to monitor: Intense competition from larger, more established Medicare Advantage insurers. This is not financial advice.

How frequently does CLOV data refresh on this page?

CLOV prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven CLOV's recent stock price performance?

Recent price movement in Clover Health Investments, Corp. (CLOV) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. The current analyst target of $3.00 implies 71% upside from here. Notable catalyst: Innovative Clover Assistant platform for data-driven care. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Should investors consider CLOV overvalued or undervalued right now?

Determining whether Clover Health Investments, Corp. (CLOV) is overvalued or undervalued requires examining multiple metrics. Analysts target $3.00 (+71% from current price), suggesting analysts see upside potential. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.

What research should beginners do before buying CLOV?

Before investing in Clover Health Investments, Corp. (CLOV), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .

Data provided for informational purposes only.

Analysis Notes
  • Financial data is based on the most recent available information. The Medicare Advantage market is subject to regulatory changes, which could impact Clover Health's business model. Future performance is not guaranteed.
Data Sources

Popular Stocks